Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Otter

Showing results (41-50 of 84) with videos related to

Pageof 9
Sort By:
British Journal of Hospital Medicine|March 2, 1996
Prostate-specific antigen (PSA) immunohistochemistry in the presence of a normal serum PSA as an aid to diagnosis of adenocarcinoma of unknown primary siteC L Harper, F J Lofts, M Otter, et al.
The Journal of Biological Chemistry|December 5, 1988
Characterization of the interaction in vivo of tissue-type plasminogen activator with liver cellsJ Kuiper, M Otter, D C Rijken, et al.
Annals of the New York Academy of Sciences|December 4, 1992
Mechanisms of tissue-type plasminogen activator (tPA) clearance by the liverM Otter, J Kuiper, T J van Berkel, et al.
Cancer Treatment Reports|May 1, 1985
New folate analogs of the 10-deaza-aminopterin series: markedly increased antitumor activity of the 10-ethyl analog compared to the parent compound and methotrexate against some human tumor xenografts in nude miceF A Schmid, F M Sirotnak, G M Otter, et al.
Child and Adolescent Psychiatry and Mental Health|January 13, 2024
The impact of the COVID-19 pandemic on rates of adolescents receiving psychopharmacological medication in AustriaM Otter, O D Kothgassner, L Lepuschütz, et al.
Journal of Medicinal Chemistry|August 7, 1992
Synthesis and antifolate evaluation of 10-ethyl-5-methyl-5,10- dideazaaminopterin and an alternative synthesis of 10-ethyl-10- deazaaminopterin (edatrexate)J R Piper, C A Johnson, G M Otter, et al.
Cancer Treatment Reports|July 1, 1987
Combination chemotherapy with a new folate analog: activity of 10-ethyl-10-deaza-aminopterin compared to methotrexate with 5-fluorouracil and alkylating agents against advanced metastatic disease in murine tumor modelsF A Schmid, F M Sirotnak, G M Otter, et al.
Cancer Treatment Reports|January 1, 1976
Deveopment of resistance to combinations of six antimetabolites in mice with L1210 leukemiaF A Schmid, D J Hutchison, G M Otter, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1994
Disposition of leucovorin and its metabolites in the plasma, intestinal epithelium, and intraperitoneal L1210 cells of methotrexate-pretreated miceM A Bunni, F M Sirotnak, G M Otter, et al.
Biochemical Pharmacology|December 15, 1988
Analogs of tetrahydrofolate directed at folate-dependent purine biosynthetic enzymes. Characteristics of mediated entry and transport-related resistance in L1210 cells for 5,10-dideazatetrahydrofolate and two 10-alkyl derivativesF M Sirotnak, G M Otter, J R Piper, et al.
Pageof 9

Showing results (41-50 of 84) with videos related to

Sort By:
Pageof 9
British Journal of Hospital Medicine|March 2, 1996
Prostate-specific antigen (PSA) immunohistochemistry in the presence of a normal serum PSA as an aid to diagnosis of adenocarcinoma of unknown primary siteC L Harper, F J Lofts, M Otter, et al.
The Journal of Biological Chemistry|December 5, 1988
Characterization of the interaction in vivo of tissue-type plasminogen activator with liver cellsJ Kuiper, M Otter, D C Rijken, et al.
Annals of the New York Academy of Sciences|December 4, 1992
Mechanisms of tissue-type plasminogen activator (tPA) clearance by the liverM Otter, J Kuiper, T J van Berkel, et al.
Cancer Treatment Reports|May 1, 1985
New folate analogs of the 10-deaza-aminopterin series: markedly increased antitumor activity of the 10-ethyl analog compared to the parent compound and methotrexate against some human tumor xenografts in nude miceF A Schmid, F M Sirotnak, G M Otter, et al.
Child and Adolescent Psychiatry and Mental Health|January 13, 2024
The impact of the COVID-19 pandemic on rates of adolescents receiving psychopharmacological medication in AustriaM Otter, O D Kothgassner, L Lepuschütz, et al.
Journal of Medicinal Chemistry|August 7, 1992
Synthesis and antifolate evaluation of 10-ethyl-5-methyl-5,10- dideazaaminopterin and an alternative synthesis of 10-ethyl-10- deazaaminopterin (edatrexate)J R Piper, C A Johnson, G M Otter, et al.
Cancer Treatment Reports|July 1, 1987
Combination chemotherapy with a new folate analog: activity of 10-ethyl-10-deaza-aminopterin compared to methotrexate with 5-fluorouracil and alkylating agents against advanced metastatic disease in murine tumor modelsF A Schmid, F M Sirotnak, G M Otter, et al.
Cancer Treatment Reports|January 1, 1976
Deveopment of resistance to combinations of six antimetabolites in mice with L1210 leukemiaF A Schmid, D J Hutchison, G M Otter, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1994
Disposition of leucovorin and its metabolites in the plasma, intestinal epithelium, and intraperitoneal L1210 cells of methotrexate-pretreated miceM A Bunni, F M Sirotnak, G M Otter, et al.
Biochemical Pharmacology|December 15, 1988
Analogs of tetrahydrofolate directed at folate-dependent purine biosynthetic enzymes. Characteristics of mediated entry and transport-related resistance in L1210 cells for 5,10-dideazatetrahydrofolate and two 10-alkyl derivativesF M Sirotnak, G M Otter, J R Piper, et al.
Pageof 9